S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
All the trading advice you’ve ever received boils down to this (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
All the trading advice you’ve ever received boils down to this (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
All the trading advice you’ve ever received boils down to this (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt

Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume

$1.47
-0.13 (-8.13%)
(As of 12/1/2023 08:55 PM ET)
Compare
Today's Range
$1.40
$1.73
50-Day Range
$1.25
$1.95
52-Week Range
$0.92
$9.54
Volume
510,100 shs
Average Volume
831,992 shs
Market Capitalization
$3.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Petros Pharmaceuticals Short Interest Data

Current Short Volume
25,800 shares
Previous Short Volume
44,200 shares
Change Vs. Previous Month
-41.63%
Dollar Volume Sold Short
$34,314.00
Short Interest Ratio / Days to Cover
0.8
Last Record Date
November 15, 2023
Outstanding Shares
2,200,000 shares
Float Size
1,320,000 shares
Short Percent of Float
1.95%
Today's Trading Volume
510,100 shares
Average Trading Volume
831,992 shares
Today's Volume Vs. Average
61%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Petros Pharmaceuticals ?

Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PTPI Short Interest Over Time

PTPI Days to Cover Over Time

PTPI Percentage of Float Shorted Over Time


Petros Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202325,800 shares $34,314.00 -41.6%2.0%0.8 $1.33
10/31/202344,200 shares $63,206.00 -27.9%3.5%1.3 $1.43
10/15/202361,300 shares $98,073.87 +415.1%4.9%1.4 $1.60
9/30/202311,900 shares $20,585.81 +213.2%0.9%0 $1.73
9/15/20233,800 shares $6,878.00 -82.3%0.3%0 $1.81
8/31/202321,500 shares $54,825.00 -62.7%1.7%0.1 $2.55
8/15/202357,700 shares $184,640.00 -21.9%3.9%0.2 $3.20
7/31/202373,900 shares $296,339.00 -79.4%5.0%0.2 $4.01
7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19
6/30/202325,100 shares $50,953.00 -27.0%1.7%0 $2.03
6/15/202334,400 shares $89,784.00 -10.7%2.3%0 $2.61
5/31/202338,500 shares $89,705.00 -13.5%2.6%0 $2.33
5/15/202344,500 shares $186,900.00 -88.5%3.0%0 $4.20
4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30
4/15/202334,100 shares $156,519.00 -22.5%2.4%0 $4.59
3/31/202344,000 shares $61,380.00 +14.9%3.1%3.1 $1.40
3/15/202338,300 shares $56,684.00 +13.0%2.7%2.1 $1.48
2/28/202333,900 shares $71,190.00 -6.6%2.4%1.6 $2.10
2/15/202336,300 shares $92,202.00 +23.1%2.5%1.8 $2.54
1/31/202329,500 shares $76,700.00 -24.4%2.1%1.5 $2.60
1/15/202339,000 shares $118,950.00 +14.0%2.7%1.6 $3.05
12/30/202234,200 shares $79,686.00 +14.8%2.4%1.4 $2.33
12/15/202229,800 shares $63,176.00 +43.3%2.1%1.8 $2.12
11/30/202220,800 shares $8,550.88 -92.2%1.4%1.5 $0.41
11/15/2022265,700 shares $130,193.00 +78.6%N/A2.1 $0.49
10/31/2022148,800 shares $71,424.00 +9.3%N/A1 $0.48
10/15/2022136,200 shares $58,525.14 +77.3%N/A0.2 $0.43
9/30/202276,800 shares $39,168.00 -36.1%N/A0.1 $0.51
9/15/2022120,200 shares $78,682.92 -7.1%N/A0.1 $0.65
8/31/2022129,400 shares $84,821.70 +45.4%N/A0.1 $0.66
8/15/202289,000 shares $71,627.20 +420.5%N/A0.1 $0.80
7/31/202217,100 shares $13,573.98 -22.3%N/A0 $0.79
7/15/202222,000 shares $18,099.40 -56.2%N/A0.1 $0.82
6/30/202250,200 shares $42,157.96 +46.8%N/A0 $0.84
6/15/202234,200 shares $26,744.40 -81.0%N/A0 $0.78
5/31/2022179,500 shares $174,976.60 +89.2%N/A0.1 $0.97
5/15/202294,900 shares $91,113.49 -30.0%N/A0.1 $0.96
4/30/2022135,600 shares $153,228.00 -26.0%N/A0.1 $1.13
4/15/2022183,300 shares $221,793.00 -39.8%N/A0.1 $1.21
3/31/2022304,400 shares $474,864.00 +15.1%N/A0.4 $1.56













PTPI Short Interest - Frequently Asked Questions

What is Petros Pharmaceuticals' current short interest?

Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 25,800 shares of PTPI short. 1.95% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest.

What is a good short interest ratio for Petros Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTPI shares currently have a short interest ratio of 1.0. Learn More on Petros Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Petros Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Petros Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Petros Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.95% of Petros Pharmaceuticals' floating shares are currently sold short.

Is Petros Pharmaceuticals' short interest increasing or decreasing?

Petros Pharmaceuticals saw a drop in short interest in November. As of November 15th, there was short interest totaling 25,800 shares, a drop of 41.6% from the previous total of 44,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Petros Pharmaceuticals' float size?

Petros Pharmaceuticals currently has issued a total of 2,200,000 shares. Some of Petros Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Petros Pharmaceuticals currently has a public float of 1,320,000 shares.

How does Petros Pharmaceuticals' short interest compare to its competitors?

1.95% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Petros Pharmaceuticals: Salarius Pharmaceuticals, Inc. (1.56%), Novan, Inc. (1.37%), Panbela Therapeutics, Inc. (1.27%), Ensysce Biosciences, Inc. (2.44%), First Wave BioPharma, Inc. (1.61%), Sonnet BioTherapeutics Holdings, Inc. (1.99%), NeuBase Therapeutics, Inc. (0.47%), Neptune Wellness Solutions Inc (0.07%), Aptevo Therapeutics Inc. (0.15%), 180 Life Sciences Corp. (2.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Petros Pharmaceuticals stock?

Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Petros Pharmaceuticals?

A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further.

How often is Petros Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:PTPI) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -